First Time Loading...

Atossa Therapeutics Inc
NASDAQ:ATOS

Watchlist Manager
Atossa Therapeutics Inc Logo
Atossa Therapeutics Inc
NASDAQ:ATOS
Watchlist
Price: 1.6 USD 1.91%
Updated: May 21, 2024

Atossa Therapeutics Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atossa Therapeutics Inc
Other Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Atossa Therapeutics Inc
NASDAQ:ATOS
Other Operating Expenses
-$3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$169m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
-$791m
CAGR 3-Years
-52%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$49.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
-$13.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Atossa Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
-3m USD

Based on the financial report for Mar 31, 2024, Atossa Therapeutics Inc's Other Operating Expenses amounts to -3m USD.